Proteome Sciences plc (AIM: PRM)
London
· Delayed Price · Currency is GBP · Price in GBX2.300
-0.450 (-16.36%)
Nov 21, 2024, 8:05 AM GMT+1
Proteome Sciences Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 4.04 | 5.03 | 7.78 | 5.13 | 4.75 | 4.66 | Upgrade
|
| Revenue Growth (YoY) | -47.92% | -35.37% | 51.69% | 7.91% | 2.08% | 52.71% | Upgrade
|
| Cost of Revenue | 3.95 | 3.38 | 3.01 | 2.17 | 2.17 | 1.7 | Upgrade
|
| Gross Profit | 0.09 | 1.65 | 4.77 | 2.96 | 2.59 | 2.95 | Upgrade
|
| Selling, General & Admin | 2.62 | 2.78 | 2.64 | 2.34 | 2.04 | 2.66 | Upgrade
|
| Operating Expenses | 3.25 | 3.27 | 3.04 | 2.55 | 2.04 | 2.66 | Upgrade
|
| Operating Income | -3.16 | -1.62 | 1.73 | 0.41 | 0.55 | 0.3 | Upgrade
|
| Interest Expense | -0.86 | -0.8 | -0.47 | -0.29 | -0.3 | -0.34 | Upgrade
|
| Pretax Income | -4.02 | -2.42 | 1.26 | 0.12 | 0.25 | -0.04 | Upgrade
|
| Income Tax Expense | 0.06 | 0.03 | -0.07 | 0.05 | -0.05 | -0.19 | Upgrade
|
| Net Income | -4.08 | -2.44 | 1.33 | 0.07 | 0.3 | 0.15 | Upgrade
|
| Net Income to Common | -4.08 | -2.44 | 1.33 | 0.07 | 0.3 | 0.15 | Upgrade
|
| Net Income Growth | - | - | 1740.28% | -75.59% | 97.99% | - | Upgrade
|
| Shares Outstanding (Basic) | 295 | 295 | 295 | 295 | 295 | 295 | Upgrade
|
| Shares Outstanding (Diluted) | 295 | 295 | 309 | 302 | 295 | 295 | Upgrade
|
| Shares Change (YoY) | -2.77% | -4.48% | 2.38% | 2.26% | - | - | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| EPS Growth | - | - | 2060.30% | -80.08% | 100.20% | - | Upgrade
|
| Free Cash Flow | -2.13 | -0.72 | 1.82 | 0.59 | 1.57 | -0.04 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.00 | 0.01 | 0.00 | 0.01 | -0.00 | Upgrade
|
| Gross Margin | 2.11% | 32.76% | 61.27% | 57.71% | 54.39% | 63.44% | Upgrade
|
| Operating Margin | -78.41% | -32.24% | 22.21% | 8.03% | 11.55% | 6.42% | Upgrade
|
| Profit Margin | -101.07% | -48.59% | 17.03% | 1.40% | 6.21% | 3.20% | Upgrade
|
| Free Cash Flow Margin | -52.89% | -14.28% | 23.41% | 11.48% | 33.03% | -0.82% | Upgrade
|
| EBITDA | -2.9 | -1.5 | 1.83 | 0.45 | 0.58 | 0.34 | Upgrade
|
| EBITDA Margin | -71.85% | -29.79% | 23.57% | 8.81% | 12.22% | 7.22% | Upgrade
|
| D&A For EBITDA | 0.27 | 0.12 | 0.11 | 0.04 | 0.03 | 0.04 | Upgrade
|
| EBIT | -3.16 | -1.62 | 1.73 | 0.41 | 0.55 | 0.3 | Upgrade
|
| EBIT Margin | -78.41% | -32.24% | 22.21% | 8.03% | 11.55% | 6.42% | Upgrade
|
| Effective Tax Rate | - | - | - | 38.98% | - | - | Upgrade
|
| Revenue as Reported | 5.03 | 5.03 | 7.78 | 5.13 | 4.75 | 4.66 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.